Phosphodiesterase type III inhibitor enhances the protective effects of adenosine against ischemic hepatic injury in rats.
Katsuragi
K
K
Second Department of Surgery, Osaka City University Medical School, Osaka, Japan.
Hirohashi
K
K
Takemura
S
S
Minamiyama
Y
Y
Tanaka
H
H
Sakata
C
C
Tanaka
S
S
Nishino
Y
Y
Shuto
T
T
Kubo
S
S
Kinoshita
H
H
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000241:Adenosine / Q000494:pharmacology*; D000818:Animals; D054684:Cyclic Nucleotide Phosphodiesterases, Type 3; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D008099:Liver / Q000098:blood supply*; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D051381:Rats; D015427:Reperfusion Injury / Q000517:prevention & control*
D010726:Phosphodiesterase Inhibitors; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D054684:Cyclic Nucleotide Phosphodiesterases, Type 3; D000241:Adenosine